Company: FLDDW
Filing Date: 2025-01-22
Form Type: S-4/A
Source: 0001213900-25-005202
Chunk: 255

Company: Fold Holdings, Inc.
Filing Date: 2025-01-22
Form: S-4/A
Chunk 255
---
 that the Sponsor or Emerald’s Board, officers, advisors or their affiliates purchase shares in privately negotiated transactions from Public Stockholders who have already elected to exercise their redemption rights, such selling stockholders would be required to revoke their prior elections to redeem their shares. Any such privately negotiated purchases may be effected at purchase prices that are in excess of the per share pro rataportion of the Trust Account. The purpose of these purchases would be to increase the amount of cash available to Emerald for use in the Business Combination. Regulatory Approvals Required for the Business Combination Under the HSR Act, as amended and related rules, certain transactions may not be completed until notifications have been given and information is furnished to the Antitrust Division of the DOJ and the FTC and all statutory waiting period requirements have been satisfied. The parties have determined that notification under the HSR Act is not required in connection with the Business Combination.

148

At any time before or after the expiration of the statutory waiting periods under the HSR Act, the Antitrust Division of the DOJ and the FTC may take action under the antitrust laws, including seeking to enjoin the completion of the Business Combination, to rescind the Business Combination or to conditionally permit completion of the Business Combination subject to regulatory conditions or other remedies. In addition, non -U.S. regulatory bodies and U.S. state attorneys general could take action under other applicable regulatory laws as they deem necessary or desirable in the public interest, including, without limitation, seeking to enjoin or otherwise prevent the completion of the Business Combination or permitting completion subject to regulatory conditions. Private parties may also seek to take legal action under regulatory laws under some circumstances. There can be no assurance that a challenge to the Business Combination on antitrust grounds will not be made or, if such a challenge is made, that it would not be successful. Emerald and Fold are not aware of any other regulatory approvals in the United States required for the consummation of the Business Combination. Accounting Treatment of the Business Combination The Business Combination is expected to be accounted for as a reverse recapitalization in accordance with GAAP. Under this method of accounting, Emerald will be treated as the acquired company and Fold will be treated as the acquirer for financial reporting purposes. Accordingly, for accounting purposes, the financial statements of New Fold will represent a continuation of the financial statements of Fold, with the Business Combination treated as the equivalent of Fold issuing stock for the historical net assets of Emerald, accompanied by a recapitalization. The net assets of Emerald will be stated at fair value,